Investigation of anxiety and depression symptom co-morbidity in a community sample with type 2 diabetes: Associations with indicators of self-care

Canadian Journal of Public Health

Volumn 106, Issue 8, 2015, Pages e496-e501

  Smith, Kimberley J ^a   Pedneault, Maxime ^b   Schmitz, Norbert ^b,c  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Anxiety; Depression; Type 2 diabetes

Indexed keywords

ADULT; AGED; ANXIETY; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PSYCHOLOGY; QUEBEC; QUESTIONNAIRE; SELF CARE;

ADULT; AGED; ANXIETY; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUEBEC; RESIDENCE CHARACTERISTICS; SELF CARE; SURVEYS AND QUESTIONNAIRES;

EID: 84961245325     PISSN: 00084263     EISSN: 19207476     Source Type: Journal    
DOI: 10.17269/CJPH.106.5170     Document Type: Article

References (24)

1. World Health Organization. Diabetes Factsheet: Number 312. World Health Organization, 2011. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/ (Accessed August 25, 2015).
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001;24:1069-78.
3. Smith KJ, Beland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: A systematic review and meta-analysis. J Psychosom Res 2013;74(2):89-99. doi:10.1016/j.jpsychores.2012.11.013.
4. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008;31:2398-403. doi:10.2337/dc08-1341.
5. Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: A prospective cohort study. Diabetes Care 2010;33:264-69. doi:10.2337/dc09-1068.
6. Schmitz N, Gariepy G, Smith KJ, Malla A, Boyer R, Strychar I, et al. Longitudinal relationships between depression and functioning in people with type 2 diabetes. Ann Behav Med 2014;47(2):172-79. doi:10.1007/s12160-013-9534-2.
7. van Dooren FE, Nefs G, Schram MT, Verhey FR, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLoS One 2013;8:e57058. doi:10.1371/journal.pone.0057058.s002.
8. Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: A meta-analysis and systematic review. Gen Hosp Psychiatry 2013;35:217-25. doi:10.1016/j.genhosppsych.2013.01.006.
9. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617-27. doi:10.1001/archpsyc.62.6.617.
10. Deschênes SS, Burns RJ, Schmitz N. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: Findings from the 2012 Canadian Community Health Survey— Mental Health (CCHS-MH). J Psychosom Res 2015;78:137-42. doi:10.1016/j.jpsychores.2014.11.023.
11. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007;29:147-55. doi:10.1016/j.genhosppsych.2006.11.005.
12. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009;26:153-61. doi:10.1111/j.1464-5491.2008.02648.x.
13. Balhara YP, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab 2011;15:S50-54. doi:10.4103/2230-8210.83057.
14. Khuwaja AK, Lalani S, Dhanani R, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors. Diabetol Metab Syndr 2010;2:72. doi:10.1186/1758-5996-2-72.
15. Smith KJ, Gariepy G, Pedneault M, Beland M, Clyde M, Schmitz N. Exploring the association of psychological status with self-rated diabetes control: Results from the Montreal Evaluation of Diabetes Treatment Study. Psychosomatics 2013;54:35-43. doi:10.1016/j.psym.2012.08.002.
16. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13. doi:10.1046/j.1525-1497.2001.016009606.x.
17. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ 2012;184:E191-96. doi:10.1503/cmaj.110829.
18. Lowe B, Decker O, Muller S, Brähler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008;46:266-74. doi:10.1097/MLR.0b013e318160d093.
19. Canadian Diabetes Association. Diabetes and You: Living with Diabetes. Canadian Diabetes Association, 2011. Available from: http://www.diabetes.ca/diabetes-and-you/living/management/ (Accessed August 25, 2015).
20. Brez S, Berard L, Blumer I. Monitoring glycemic control. Can J Diabetes 2008;32(Suppl 1):S32-36.
21. Smith KJ, Page V, Gariepy G, Béland M, Badawi G, Schmitz N. Self-rated diabetes control in a Canadian population with type 2 diabetes: Associations with health behaviours and outcomes. Diabetes Res Clin Pract 2012;95:162-68. doi:10.1016/j.diabres.2011.10.019.
22. Fincke BG, Clark JA, Linzer M, Spiro A 3rd, Miller DR, Lee A, et al. Assessment of long-term complications due to type 2 diabetes using patient self-report: The Diabetes Complications Index. J Ambul Care Manage 2005;28:262-73. doi:10.1097/00004479-200507000-00010.
23. Statistics Canada: Canadian Community Health Survey Mental Health and Well-being Cycle 1.2. Master File Documentation. Statistics Canada 2003, Ottawa, Canada. 2003.
24. Lepine J-P. Epidemiology, burden, and disability in depression and anxiety. J Clin Psychiatry 2001;62(Suppl 13):4-10.